IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2007;48:1472-1475.)
© 2007 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.06-0766

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sutter, F. K. P.
Right arrow Articles by Helbig, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sutter, F. K. P.
Right arrow Articles by Helbig, H.

Is Pseudophakia a Risk Factor for Neovascular Age-Related Macular Degeneration?

Florian K. P. Sutter, Moreno Menghini, Daniel Barthelmes, Johannes C. Fleischhauer, Malaika M. Kurz-Levin, Martina M. Bosch, and Horst Helbig

From the Department of Ophthalmology, University Hospital, Zurich, Switzerland.

PURPOSE. To examine the possible association between pseudophakia and neovascular age-related macular degeneration (AMD).

METHODS. Reports of all patients undergoing fluorescein angiography in the authors’ department over a 6-year period were retrospectively reviewed. Four hundred ninety-nine patients with recent onset of neovascular AMD in one eye and early age-related maculopathy (ARM) in the fellow eye were included in the study. Lens status (phakic or pseudophakic) in both eyes at the time of onset of neovascular AMD and the time between cataract surgeries (if performed) and onset of neovascular AMD were determined.

RESULTS. There was no significant difference in lens status between eyes with neovascular AMD and fellow eyes with early ARM (115/499 [23.0%] vs. 112/499 [22.4%] pseudophakic; P = 0.88, odds ratio 1.035, 95% CI 0.770–1.391). Subgroup analysis revealed no difference between the groups with large drusen, small drusen, or pigmentary changes only (respectively, 20.3% vs. 19.6% pseudophakic, P = 0.92; 20.5% vs. 23.3% pseudophakic, P = 0.84; 33.3% vs. 31.7% pseudophakic, P = 1.0). Pseudophakic eyes with neovascular AMD had not been pseudophakic for a significantly longer period at the time of onset of neovascular AMD than their pseudophakic fellow eyes at the same time point (225.9 ± 170.4 vs. 209.9 ± 158.2 weeks, P = 0.27).

CONCLUSIONS. The results do not support the hypothesis that pseudophakia is a major risk factor for the development of neovascular AMD.





This article has been cited by other articles:


Home page
IOVSHome page
H. Baatz, R. Darawsha, H. Ackermann, G. B. Scharioth, D. de Ortueta, M. Pavlidis, and L. O. Hattenbach
Phacoemulsification Does Not Induce Neovascular Age-Related Macular Degeneration
Invest. Ophthalmol. Vis. Sci., March 1, 2008; 49(3): 1079 - 1083.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the Association for Research in Vision and Ophthalmology